Qing Xi Ooi
Qing Xi Ooi
MIDD Consultant, Pharmetheus AB
Verified email at
Cited by
Cited by
A joint model for vitamin K-dependent clotting factors and anticoagulation proteins
QX Ooi, DFB Wright, RC Tait, GK Isbister, SB Duffull
Clinical pharmacokinetics 56, 1555-1566, 2017
Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes
Y Tomita, E Hansson, F Mazuir, GJ Wellhagen, QX Ooi, E Mezzalana, ...
Clinical and Translational Science 15 (4), 1014-1026, 2022
Evaluation of assumptions underpinning pharmacometric models
QX Ooi, DFB Wright, GK Isbister, SB Duffull
The AAPS journal 21, 1-11, 2019
A factor VII-based method for the prediction of anticoagulant response to warfarin
QX Ooi, DFB Wright, GK Isbister, SB Duffull
Scientific Reports 8 (1), 12041, 2018
On the preferred structure of dicoumarol and implications for enzyme binding: A quantum chemical analysis
BM Hussain, K Hassam, QX Ooi, RA Bryce
Chemical Physics Letters 602, 45-51, 2014
Kinetic‐pharmacodynamic model for drugs with non‐linear elimination: Parameterisation matters
QX Ooi, C Hasegawa, SB Duffull, DFB Wright
British Journal of Clinical Pharmacology 86 (2), 196, 2020
Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357
QX Ooi, A Kristoffersson, J Korell, M Flack, E L. Plan, B Weber
CPT: Pharmacometrics & Systems Pharmacology, 2023
Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and …
RJ Svensson, QX Ooi, LE Friberg, N Maharaj, PK Reddy, L López‐Lázaro, ...
CPT: Pharmacometrics & Systems Pharmacology 12 (2), 154-167, 2023
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study
WY Mak, QX Ooi, CV Cruz, I Looi, KH Yuen, JF Standing
British journal of clinical pharmacology 89 (1), 330-339, 2023
Application of pharmacometric methods to understand warfarin dose response
QX Ooi
University of Otago, 2018
Rituximab PK and PKPD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity.
RJ Svensson, QX Ooi, LE Friberg, N Maharaj, PK Reddy, L López-Lázaro, ...
CPT: Pharmacometrics & Systems Pharmacology, 2022
Population pharmacokinetic modeling and simulation of imeglimin in type 2 diabetes patients to support dose recommendations to patients with renal impairment
E Mezzalana, Y Tomita, E Hansson, F Mazuir, G Wellhagen, QX Ooi, ...
Age 62 (32), 83, 0
The system can't perform the operation now. Try again later.
Articles 1–12